|
1.
|
|
11 p, 1.2 MB |
CD200 genotype is associated with clinical outcome of patients with multiple myeloma
/
Gonzalez-Montes, Yolanda (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Osca-Gelis, Gemma (Universitat de Girona) ;
Rodriguez-Romanos, Rocío (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Villavicencio, Alicia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
González-Bártulos, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Llopis, Francesca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Clapes, Victòria (Institut d'Investigació Biomèdica de Bellvitge) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sureda, Anna (Universitat de Barcelona) ;
Escoda, Lourdes (Universitat Rovira i Virgili) ;
Sarrà, Josep (Universitat Rovira i Virgili) ;
Garzó, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Lloveras, Natàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Gómez, Beatriz (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Gallardo, David (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Immune dysfunction in patients with MM affects both the innate and adaptive immune system. Molecules involved in the immune response pathways are essential to determine the ability of cancer cells to escape from the immune system surveillance. [...]
2024 -  10.3389/fimmu.2024.1252445
Frontiers in immunology, Vol. 15 (2024) , p. 1252445
|
|
|
2.
|
|
8 p, 946.7 KB |
Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement
/
Moreno Martinez, Maria Estela (Institut de Recerca Sant Pau) ;
Riba, Mireia (Institut de Recerca Sant Pau) ;
Garcia Cadenas, Irene (Institut de Recerca Sant Pau) ;
Esquirol, Albert (Institut de Recerca Sant Pau) ;
Yusta, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Redondo, Sara (Institut d'Investigació Biomèdica Sant Pau) ;
De Dios, Anna (Institut de Recerca Sant Pau) ;
Portos, José Manuel (Institut d'Investigació Biomèdica Sant Pau) ;
Aso, Olga (Institut d'Investigació Biomèdica Sant Pau) ;
Marcos Fendian, Ángel (Institut de Recerca Sant Pau) ;
Font, Núria (Institut d'Investigació Biomèdica Sant Pau) ;
Briones Meijide, Javier (Institut de Recerca Sant Pau) ;
Martino Bofarull, Rodrigo (Institut de Recerca Sant Pau) ;
Feliu, Anna (Institut de Recerca Sant Pau) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Home hospitalization represents an alternative to traditional hospitalization, providing comparable clinical safety for hematological patients. At-home therapies can range from the delivery of intravenous antibiotics to more complex scenarios, such as the care during the early period after hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy. [...]
2024 - 10.3389/fimmu.2024.1397115
Frontiers in immunology, Vol. 15 (2024) , p. 1397115
|
|
|
3.
|
|
2 p, 231.7 KB |
Corrigendum : Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes(Front. Immunol., (2022), 13, (825426), 10.3389/fimmu.2022.825426)
/
Gómez Muñoz, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Perna-Barrull, David (Institut Germans Trias i Pujol) ;
Caroz-Armayones, Josep M. (Universitat Pompeu Fabra) ;
Murillo-Vallés, Marta (Institut Germans Trias i Pujol) ;
Rodríguez-Fernández, Silvia (Institut Germans Trias i Pujol) ;
Valls, Aina (Institut Germans Trias i Pujol) ;
Vázquez, Federico (Institut Germans Trias i Pujol) ;
Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Corripio, Raquel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Castaño, Luis (Instituto de Investigación Sanitaria Biocruces Bizkaia) ;
Bel, Joan (Institut Germans Trias i Pujol) ;
Vives Pi, Marta (Institut Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona.
Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública
In the published article, there was an error in the Funding statement. One of the funding bodies was incorrectly listed as "the Spanish Government (FIS PI18/00436)". The correct Funding statement appears below.
2024 - 10.3389/fimmu.2024.1439643
Frontiers in immunology, Vol. 15 (2024) , p. 1439643
|
|
|
4.
|
|
1 p, 222.8 KB |
Corrigendum : NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes(Front Immunol., 11, (611522), 10.3389/fimmu.2020.611522)
/
Gómez Muñoz, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Perna-Barrull, David (Institut Germans Trias i Pujol) ;
Villalba Felipe, Adrián (Institut Germans Trias i Pujol) ;
Rodríguez-Fernández, Silvia (Institut Germans Trias i Pujol) ;
Ampudia Carrasco, Rosa María (Institut Germans Trias i Pujol) ;
Teniente Serra, Aina (Institut Germans Trias i Pujol) ;
Vázquez, Federico (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Murillo-Vallés, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pérez Sánchez, Jacobo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Corripio, Raquel (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
Bel, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vives Pi, Marta (Institut Germans Trias i Pujol)
In the published article, there was an error in the Funding statement. The Funding statement was displayed as "This work has been funded by the Spanish Government (FIS PI18/00436) co-financed with the European Regional Development funds (FEDER), and by DiabetesCero Foundation. [...]
2024 - 10.3389/fimmu.2024.1439246
Frontiers in immunology, Vol. 15 (2024) , p. 1439246
|
|
|
5.
|
|
13 p, 3.2 MB |
Zinc deficiency impairs axonal regeneration and functional recovery after spinal cord injury by modulating macrophage polarization via NF-κB pathway
/
Kijima, Ken (University of Southern California) ;
Ono, Gentaro (Department of Orthopedic Surgery, Kyushu University) ;
Kobayakawa, Kazu (Department of Orthopedic Surgery, Kyushu University) ;
Saiwai, Hirokazu (Department of Orthopedic Surgery, Kyushu University) ;
Hara, Masamitsu (Department of Orthopedic Surgery, Kyushu University) ;
Yoshizaki, Shingo (Department of Orthopedic Surgery, Kyushu University) ;
Yokota, Kazuya (Department of Orthopedic Surgery, Kyushu University) ;
Saito, Takeyuki (Department of Orthopedic Surgery, Kyushu University) ;
Tamaru, Tetsuya (Department of Orthopedic Surgery, Kyushu University) ;
Iura, Hirotaka (Department of Orthopedic Surgery, Kyushu University) ;
Haruta, Yohei (Department of Orthopedic Surgery, Kyushu University) ;
Kitade, Kazuki (Department of Orthopedic Surgery, Kyushu University) ;
Utsunomiya, Takeshi (Department of Orthopedic Surgery, Kyushu University) ;
Konno, Daijiro (Department of Energy and Materials, Kindai University) ;
Edgerton, Victor (Institut Germans Trias i Pujol. Institut Guttmann) ;
Liu, Charles Y (University of Southern California) ;
Sakai, Hiroaki (Department of Orthopaedic Surgery, Spinal Injuries Center) ;
Maeda, Takeshi (Department of Orthopaedic Surgery, Spinal Injuries Center) ;
Kawaguchi, Kenichi (Department of Orthopedic Surgery, Kyushu University) ;
Matsumoto, Yoshihiro (Department of Orthopaedic Surgery, Fukushima Medical University) ;
Okada, Seiji (Department of Orthopedic Surgery, Osaka University Graduate School of Medicine) ;
Nakashima, Yasuharu (Department of Orthopedic Surgery, Kyushu University) ;
Universitat Autònoma de Barcelona
Spinal cord injury (SCI) is a devastating disease that results in permanent paralysis. Currently, there is no effective treatment for SCI, and it is important to identify factors that can provide therapeutic intervention during the course of the disease. [...]
2023 - 10.3389/fimmu.2023.1290100
Frontiers in immunology, Vol. 14 (november 2023)
|
|
|
6.
|
|
7 p, 6.1 MB |
Case Report : X-Linked SASH3 Deficiency Presenting as a Common Variable Immunodeficiency
/
Labrador Horrillo, Moises (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Franco-Jarava, Clara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia-Prat, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Parra-Martínez, Alba (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Antolín, María (Hospital Universitari Vall d'Hebron) ;
Salgado-Perandrés, Sandra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Aguiló-Cucurull, Aina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martínez Gallo, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
SASH3 is a lymphoid-specific adaptor protein. In a recent study, SASH3 deficiency was described as a novel X-linked combined immunodeficiency with immune dysregulation, associated with impaired TCR signaling and thymocyte survival in humans. [...]
2022 - 10.3389/fimmu.2022.881206
Frontiers in immunology, Vol. 13 (april 2022)
|
|
|
7.
|
|
8 p, 1.6 MB |
Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene : A Case Report
/
Franco-Jarava, Clara (Hospital Universitari Vall d'Hebron) ;
Valenzuela, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Riviere, Jacques G. (Hospital Universitari Vall d'Hebron) ;
Garcia-Prat, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martínez Gallo, Mónica (Jeffrey Modell Foundation Excellence Center) ;
Dieli-Crimi, Romina (Jeffrey Modell Foundation Excellence Center) ;
Castells Sarret, Neus (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Batlle-Masó, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Soler-Palacín, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. [...]
2022 - 10.3389/fimmu.2022.897975
Frontiers in immunology, Vol. 13 (june 2022)
|
|
|
8.
|
|
10 p, 531.5 KB |
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
/
Del Pozo, Victoria (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Bobolea, Irina (Hospital Clínic i Provincial de Barcelona) ;
Rial, Manuel J. (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Espigol Frigolé, Georgina (Hospital Clínic i Provincial de Barcelona) ;
Solans, Roser (Hospital Universitari Vall d'Hebron) ;
Hernández Rivas, Jesús María (Hospital Universitario de Salamanca) ;
Mora, Elvira (Hospital Universitari i Politècnic La Fe (València)) ;
Crespo Lessmann, Astrid (Institut d'Investigació Biomèdica Sant Pau) ;
Izquierdo Alonso, José Luis (Hospital Universitario de Guadalajara) ;
Domínguez Sosa, María Sandra (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Maza Solano, Juan (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Atienza-Mateo, Belén (Instituto de Investigación Marqués de Valdecilla) ;
Bañas-Conejero, David (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Moure, Abraham L. (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Rua Figueroa, Íñigo (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Eosinophil-related diseases represent a group of pathologic conditions with highly heterogeneous clinical presentation and symptoms ranging from mild to critical. Both systemic and localized forms of disease are typically treated with glucocorticoids. [...]
2024 - 10.3389/fimmu.2023.1310211
Frontiers in immunology, Vol. 14 (january 2024)
|
|
|
9.
|
|
10 p, 598.4 KB |
Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome : a 3-year follow-up cohort study
/
Park, Hye-Sang (Institut de Recerca Sant Pau) ;
Martinez-Martinez, Laura (Institut de Recerca Sant Pau) ;
Magallares López, Berta Paula (Institut de Recerca Sant Pau) ;
Castellvi, Ivan (Institut de Recerca Sant Pau) ;
Moya, Patricia (Institut de Recerca Sant Pau) ;
Codes-Mendez, Helena (Institut de Recerca Sant Pau) ;
Hernández-de Sosa, Nerea (Institut de Recerca Sant Pau) ;
Díaz Torne, César (Institut de Recerca Sant Pau) ;
Laiz, Ana (Institut de Recerca Sant Pau) ;
Sainz, Luis (Institut de Recerca Sant Pau) ;
Tandaipan, Jose Luis (Institut de Recerca Sant Pau) ;
Mariscal, Anaís (Institut de Recerca Sant Pau) ;
Franco-Leyva, Teresa (Institut de Recerca Sant Pau) ;
Casademont i Pou, Jordi (Institut de Recerca Sant Pau) ;
Juarez, Candido (Institut de Recerca Sant Pau) ;
Corominas, Hèctor (Institut de Recerca Sant Pau) ;
Universitat Autònoma de Barcelona
This was an ambispective cohort study evaluating the prognostic significance of lymphocytic foci and its lymphoid composition in minor salivary gland biopsy (MSGB) for short-term disease flare and severity in Sjögren's syndrome (SS). [...]
2024 - 10.3389/fimmu.2024.1332924
Frontiers in immunology, Vol. 15 (february 2024)
|
|
|
10.
|
|
2 p, 292.1 KB |
Corrigendum : The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)
/
Navarro-Compán, Victoria (Hospital Universitario La Paz (Madrid)) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ;
Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ;
Llamas-Velasco, Mar (Hospital Universitario de la Princesa (Madrid)) ;
Fernández-Carballido, Cristina (Hospital Universitario San Juan de Alicante) ;
Almodóvar, Raquel (Hospital Universitario Fundación Alcorcón) ;
Pinto, José Antonio (Complejo Hospitalario Universitario de A Coruña) ;
Galíndez Agirregoikoa, Eva (Hospital de Basurto (Bilbao, Biscaia)) ;
Zarco, Pedro (Hospital Universitario Fundación Alcorcón) ;
Joven, Beatriz (Hospital 12 de Octubre (Madrid)) ;
Gratacós, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Juanola, Xavier (Hospital Universitari de Bellvitge) ;
Blanco, Ricardo (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Arias-Santiago, Salvador (Universidad de Granada) ;
Sanz Sanz, Jesús (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Queiro, Ruben (Hospital Universitario Central de Asturias) ;
Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
In the published article, there was an error in Table 1 as published. The cell corresponding to ixekizumab in HS must be yellow rather than green, since it is not approved for that indication, nor has phase 3 clinical development been published. [...]
2023 - 10.3389/fimmu.2023.1332177
Frontiers in immunology, Vol. 14 (2023) , p. 1332177
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
